Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
Br J Haematol
; 165(4): 497-503, 2014 May.
Article
in En
| MEDLINE
| ID: mdl-24528179
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Leukemia, Promyelocytic, Acute
/
Antineoplastic Combined Chemotherapy Protocols
/
Consolidation Chemotherapy
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Language:
En
Year:
2014
Type:
Article